Guidelines for Clinical Research on Acupuncture
(1995; 68 pages)
Table of Contents
View the documentForeword
Open this folder and view contents1. Introduction
Open this folder and view contents2. Glossary
Open this folder and view contents3. Goals and objectives of the guidelines
Open this folder and view contents4. General considerations
Close this folder5. Research methodology
View the documentLiterature review
View the documentTerminology and technology
View the documentInvestigators
View the documentClinical research design and rational use of acupuncture
View the documentRandomized controlled clinical trial design
View the documentProtocol development
View the documentResearch knowledge
View the documentCase report forms
View the documentData management
View the documentEthics review board
View the documentStatistical analysis
View the documentMonitoring of studies
View the documentReporting
View the documentImplementation
View the documentConclusions
View the document6. Using the guidelines
Open this folder and view contentsAnnexes
View the documentBibliography
View the documentSelected WHO publications of related interest
View the documentBack cover

Monitoring of studies

A formal procedure for the systematic monitoring of a research project or programme will greatly contribute to its success. Monitoring should be done throughout the period of implementation, and cease only at completion.

Because the therapeutic effect of acupuncture is often observed to continue for a period of time after the completion of a course of treatment, it is recommended that follow-up assessment of subjects should be conducted, particularly in exploratory protocols. The follow-up time may depend on the duration of effects of acupuncture. Inappropriately long or short follow-up times can skew results.

The following elements of the programme or project should be examined: goals, conformity of protocols with goals, progress of the research towards intended goals, and the impact of the research.

The outcome of the study should be evaluated with regard to:

1. the condition of the patient before treatment;

2. the progress of the patient’s disease stated in terms of both the objective observation made by the investigator or assessor and the patient’s own assessment; and

3. any adverse event that may have occurred during the study.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017